Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
allogeneic cell therapy
Biotech
Gilead's Kite erodes $2.3B Shoreline cell therapy deal
The pact to pursue off-the-shelf CAR-NK therapies for blood cancers ended in the first quarter of this year, a Gilead spokesperson confirmed.
Darren Incorvaia
Sep 3, 2025 3:18pm
Wugen woos VCs, landing $115M to bring CAR-T therapy to market
Aug 27, 2025 8:10am
Cell therapy biotech Appia shuts down as funding runs dry
Aug 25, 2025 5:55pm
Allogene reports patient death tied to mAb in CAR-T pivotal trial
Aug 1, 2025 8:30am
Cell therapy biotech Adicet sheds 30% of staffers
Jul 24, 2025 10:20am
Allogene lays off 28% of staff to save cash amid program delays
May 14, 2025 8:00am
